<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00803998</url>
  </required_header>
  <id_info>
    <org_study_id>93.01</org_study_id>
    <nct_id>NCT00803998</nct_id>
  </id_info>
  <brief_title>Ocular Hypertension Treatment Study (OHTS)</brief_title>
  <official_title>Ocular Hypertension Treatment Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The New York Eye &amp; Ear Infirmary</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Eye Institute (NEI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>The New York Eye &amp; Ear Infirmary</source>
  <brief_summary>
    <textblock>
      The Ocular Hypertension Treatment Study is a multi-center clinical trial sponsored by the
      National Eye Institute, designed to determine the efficacy and safety of topically
      administered eye lowering medication
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>February 1994</start_date>
  <completion_date>December 2006</completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <condition>Ocular Hypertension</condition>
  <condition>Glaucoma</condition>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Qualifying IOP in at least one eye of each participant must be more than or equal 24
             mmHg but less than or equal to 32 mm HG calculated from two separate consecutive
             determination taken at least 2 hours, but not greater than 12 weeks apart.

          -  Normal and reliable 30-2 Humphrey Visual Fields in both eyes.

          -  Normal Optic disc in both eyes on clinical examinations and stereoscopic photographs
             as determined by the Optic Disc Reading Center.

        Exclusion Criteria:

          -  Visual acuity worse than 20/40 in either eye on qualifying exam.

          -  Previous intraocular surgery: laser trabeculoplasty, laser iridotomy, filtering
             surgery, combined cataract extraction/filtering procedures, penetrating keratoplasty
             and retinal detachment repair.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael Kass, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Washington University School of Medicine at St. Louis, St. Louis, Missouri</affiliation>
  </overall_official>
  <reference>
    <citation>Gordon MO, Beiser JA, Brandt JD, Heuer DK, Higginbotham EJ, Johnson CA, Keltner JL, Miller JP, Parrish RK 2nd, Wilson MR, Kass MA. The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002 Jun;120(6):714-20; discussion 829-30.</citation>
    <PMID>12049575</PMID>
  </reference>
  <verification_date>December 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 5, 2008</study_first_submitted>
  <study_first_submitted_qc>December 5, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 8, 2008</study_first_posted>
  <last_update_submitted>October 31, 2013</last_update_submitted>
  <last_update_submitted_qc>October 31, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 1, 2013</last_update_posted>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension</mesh_term>
    <mesh_term>Ocular Hypertension</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

